Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 321

    1.

    Chronic central melanocortin-4 receptor antagonism and central neuropeptide-Y infusion in rats produce increased adiposity by divergent pathways.

    Baran K, Preston E, Wilks D, Cooney GJ, Kraegen EW, Sainsbury A.

    Diabetes. 2002 Jan;51(1):152-8.PMID: 11756335 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Chronic blockade of the melanocortin 4 receptor subtype leads to obesity independently of neuropeptide Y action, with no adverse effects on the gonadotropic and somatotropic axes.

    Raposinho PD, Castillo E, d'Alleves V, Broqua P, Pralong FP, Aubert ML.

    Endocrinology. 2000 Dec;141(12):4419-27.PMID: 11108250 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Adrenalectomy prevents the obesity syndrome produced by chronic central neuropeptide Y infusion in normal rats.

    Sainsbury A, Cusin I, Rohner-Jeanrenaud F, Jeanrenaud B.

    Diabetes. 1997 Feb;46(2):209-14.PMID: 9000696 [PubMed - indexed for MEDLINE]Related articles

    5.

    Intracerebroventricular administration of neuropeptide Y to normal rats increases obese gene expression in white adipose tissue.

    Sainsbury A, Cusin I, Doyle P, Rohner-Jeanrenaud F, Jeanrenaud B.

    Diabetologia. 1996 Mar;39(3):353-6.PMID: 8721783 [PubMed - indexed for MEDLINE]Related articles

    6.

    Long-term administration of MC4 receptor antagonist HS014 causes hyperphagia and obesity in rats.

    Kask A, Pähkla R, Irs A, Rägo L, Wikberg JE, Schiöth HB.

    Neuroreport. 1999 Mar 17;10(4):707-11.PMID: 10208535 [PubMed - indexed for MEDLINE]Related articles

    7.

    Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat.

    Wang Q, Bing C, Al-Barazanji K, Mossakowaska DE, Wang XM, McBay DL, Neville WA, Taddayon M, Pickavance L, Dryden S, Thomas ME, McHale MT, Gloyer IS, Wilson S, Buckingham R, Arch JR, Trayhurn P, Williams G.

    Diabetes. 1997 Mar;46(3):335-41.PMID: 9032086 [PubMed - indexed for MEDLINE]Related articles

    8.

    Induction and reversibility of an obesity syndrome by intracerebroventricular neuropeptide Y administration to normal rats.

    Vettor R, Zarjevski N, Cusin I, Rohner-Jeanrenaud F, Jeanrenaud B.

    Diabetologia. 1994 Dec;37(12):1202-8.PMID: 7895949 [PubMed - indexed for MEDLINE]Related articles

    9.

    Selective dependence of intracerebroventricular neuropeptide Y-elicited effects on central glucocorticoids.

    Zakrzewska KE, Sainsbury A, Cusin I, Rouru J, Jeanrenaud B, Rohner-Jeanrenaud F.

    Endocrinology. 1999 Jul;140(7):3183-7.PMID: 10385413 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Orexigenic effect of the melanocortin MC4 receptor antagonist HS014 is inhibited only partially by neuropeptide Y Y1 receptor selective antagonists.

    Kask A, Schiöth HB, Harro J, Wikberg JE, Rägo L.

    Can J Physiol Pharmacol. 2000 Feb;78(2):143-9.PMID: 10737677 [PubMed - indexed for MEDLINE]Related articles

    11.

    Intracerebroventricular administration of neuropeptide Y to normal rats has divergent effects on glucose utilization by adipose tissue and skeletal muscle.

    Zarjevski N, Cusin I, Vettor R, Rohner-Jeanrenaud F, Jeanrenaud B.

    Diabetes. 1994 Jun;43(6):764-9.PMID: 8194661 [PubMed - indexed for MEDLINE]Related articles

    12.

    Effects of streptozotocin-induced diabetes and insulin treatment on the hypothalamic melanocortin system and muscle uncoupling protein 3 expression in rats.

    Havel PJ, Hahn TM, Sindelar DK, Baskin DG, Dallman MF, Weigle DS, Schwartz MW.

    Diabetes. 2000 Feb;49(2):244-52.PMID: 10868941 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    The effect of moxonidine on feeding and body fat in obese Zucker rats: role of hypothalamic NPY neurones.

    Bing C, King P, Pickavance L, Brown M, Ziegler D, Kaan E, Williams G.

    Br J Pharmacol. 1999 May;127(1):35-42.PMID: 10369453 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Chronic administration of neuropeptide Y into the lateral ventricle of C57BL/6J male mice produces an obesity syndrome including hyperphagia, hyperleptinemia, insulin resistance, and hypogonadism.

    Raposinho PD, Pierroz DD, Broqua P, White RB, Pedrazzini T, Aubert ML.

    Mol Cell Endocrinol. 2001 Dec 20;185(1-2):195-204.PMID: 11738809 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effects of intravenously infused leptin on insulin sensitivity and on the expression of uncoupling proteins in brown adipose tissue.

    Rouru J, Cusin I, Zakrzewska KE, Jeanrenaud B, Rohner-Jeanrenaud F.

    Endocrinology. 1999 Aug;140(8):3688-92.PMID: 10433228 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Chronic central neuropeptide Y infusion in normal rats: status of the hypothalamo-pituitary-adrenal axis, and vagal mediation of hyperinsulinaemia.

    Sainsbury A, Rohner-Jeanrenaud F, Cusin I, Zakrzewska KE, Halban PA, Gaillard RC, Jeanrenaud B.

    Diabetologia. 1997 Nov;40(11):1269-77.PMID: 9389418 [PubMed - indexed for MEDLINE]Related articles

    17.

    Neuropeptide Y1 and Y5 receptors mediate the effects of neuropeptide Y on the hypothalamic-pituitary-thyroid axis.

    Fekete C, Sarkar S, Rand WM, Harney JW, Emerson CH, Bianco AC, Beck-Sickinger A, Lechan RM.

    Endocrinology. 2002 Dec;143(12):4513-9.PMID: 12446577 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Chronic central leptin infusion enhances insulin-stimulated glucose metabolism and favors the expression of uncoupling proteins.

    Cusin I, Zakrzewska KE, Boss O, Muzzin P, Giacobino JP, Ricquier D, Jeanrenaud B, Rohner-Jeanrenaud F.

    Diabetes. 1998 Jul;47(7):1014-9.PMID: 9648822 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Effects of chronic murine and human leptin infusion on plasma leptin and corticosterone levels and energy balance in lean Zucker rats.

    Al-Barazanji KA, Buckingham RE, Arch JR, Briscoe C, Jenkins O, Tadayyon M.

    Diabetes Obes Metab. 2001 Dec;3(6):435-42.PMID: 11903416 [PubMed - indexed for MEDLINE]Related articles

    20.

    Severe leptin resistance in brown fat-deficient uncoupling protein promoter-driven diphtheria toxin A mice despite suppression of hypothalamic neuropeptide Y and circulating corticosterone concentrations.

    Mantzoros CS, Frederich RC, Qu D, Lowell BB, Maratos-Flier E, Flier JS.

    Diabetes. 1998 Feb;47(2):230-8. Erratum in: Diabetes 1998 May;47(5):855. PMID: 9519718 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data